GENEALEX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GENEALEX
Largest movements
- Receivables within one year +€65,432
up €65,432 (+52.7%), from €124,101 to €189,532
of which Trade receivables: +€55,603
- Intangible fixed assets -€16,732
down €16,732 (-18.9%), from €88,319 to €71,587
- Cash -€14,003
down €14,003 (-87.7%), from €15,970 to €1,967
mainly Receivables within one year (-€65,432)
- Trade debts +€17,451
up €17,451 (+64.7%), from €26,992 to €44,443
- Other debts +€12,958
up €12,958 (+2.3%), from €565,507 to €578,465
- Profit (loss) carried forward +€4,288
up €4,288 (+0.8%), from -€562,873 to -€558,585
- Depreciation -€22,500
down €22,500 (-57.4%), from €39,232 to €16,732
- Gross operating margin -€3,834
down €3,834 (-7.5%), from €51,398 to €47,564
- Financial charges +€3,091
up €3,091 (+13.4%), from €23,067 to €26,158
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €228,389 | €263,086 | +€34,697 | +15.2% |
| Fixed assets | 21/28 | €88,319 | €71,587 | -€16,732 | -18.9% |
| Intangible fixed assets | 21 | €88,319 | €71,587 | -€16,732 | -18.9% |
| Current assets | 29/58 | €140,071 | €191,499 | +€51,428 | +36.7% |
| Amounts receivable within one year | 40/41 | €124,101 | €189,532 | +€65,432 | +52.7% |
| Trade receivables | 40 | €123,453 | €179,056 | +€55,603 | +45.0% |
| Other amounts receivable | 41 | €647 | €10,477 | +€9,829 | +1518.7% |
| Cash at bank and in hand | 54/58 | €15,970 | €1,967 | -€14,003 | -87.7% |
| Total equity and liabilities | 10/49 | €228,389 | €263,086 | +€34,697 | +15.2% |
| Equity | 10/15 | -€462,873 | -€458,585 | +€4,288 | +0.9% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Capital | 10 | €100,000 | €100,000 | = | 0.0% |
| Issued capital | 100 | €100,000 | €100,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€562,873 | -€558,585 | +€4,288 | +0.8% |
| Amounts payable | 17/49 | €691,262 | €721,671 | +€30,409 | +4.4% |
| Amounts payable after more than one year | 17 | €98,763 | €98,763 | = | 0.0% |
| Financial debts | 170/4 | €98,763 | €98,763 | = | 0.0% |
| Amounts payable within one year | 42/48 | €592,499 | €622,908 | +€30,409 | +5.1% |
| Trade debts | 44 | €26,992 | €44,443 | +€17,451 | +64.7% |
| Suppliers | 440/4 | €26,992 | €44,443 | +€17,451 | +64.7% |
| Other amounts payable | 47/48 | €565,507 | €578,465 | +€12,958 | +2.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €39,232 | €16,732 | -€22,500 | -57.4% |
| Other operating charges | 640/8 | €384 | €387 | +€3 | +0.8% |
| Gross operating margin | 9900 | €51,398 | €47,564 | -€3,834 | -7.5% |
| Operating profit (loss) | 9901 | €11,781 | €30,445 | +€18,663 | +158.4% |
| Financial income | 75/76B | - | €1 | +€1 | |
| Recurring financial income | 75 | - | €1 | +€1 | |
| Financial charges | 65/66B | €23,067 | €26,158 | +€3,091 | +13.4% |
| Recurring financial charges | 65 | €23,067 | €26,158 | +€3,091 | +13.4% |
| Profit (loss) for the period before taxes | 9903 | -€11,285 | €4,288 | +€15,573 | |
| Profit (loss) for the period | 9904 | -€11,285 | €4,288 | +€15,573 | |
| Profit (loss) for the period to be appropriated | 9905 | -€11,285 | €4,288 | +€15,573 |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.